Associated Papers
Association of Cannabinoid CB2 Receptor Q63R Variant With Rheumatoid Arthritis in an Iranian Cohort.
Nateghi A et al.
International Journal of Genomics, 2025
Genomic and clinical characterization of pediatric lymphoepithelioma-like carcinoma.
Que Y et al.
Journal of Translational Medicine, 2024
Cannabinoid Receptor 2 Gene Polymorphism and the Risk of Developing Rheumatoid Arthritis in Lebanese Patients.
Ismail M et al.
Cannabis and Cannabinoid Research, 2024
Association Between the Endocannabinoid System-Related Gene Variants and Epilepsy.
Hosseinzadeh Anvar L et al.
Molecular Neurobiology, 2024
Genetic variants in patients with multiple arterial aneurysms.
Körfer D et al.
Langenbeck's Archives of Surgery, 2024
In utero tumor development and identification of CTNNB1 mutation in a newborn case of ossifying renal tumor of infancy.
Kasai S et al.
Pediatric Blood & Cancer, 2024
Novel NARS2 variants in a patient with early-onset status epilepticus: case study and literature review.
Yang N et al.
Bmc Pediatrics, 2024
Genomic and transcriptomic analysis of breast cancer identifies novel signatures associated with response to neoadjuvant chemotherapy.
Yin G et al.
Genome Medicine, 2024
Bi-allelic mutation in SEC16B alters collagen trafficking and increases ER stress.
El-Gazzar A et al.
Embo Molecular Medicine, 2023
Molecular underpinnings of exceptional response in primary malignant melanoma of the esophagus to anti-PD-1 monotherapy.
Dai J et al.
Journal for Immunotherapy of Cancer, 2023
ATR represents a therapeutic vulnerability in clear cell renal cell carcinoma.
Seidel P et al.
Jci Insight, 2022
Functional variation (Q63R) in the cannabinoid CB2 receptor may affect the severity of COVID-19: a human study and molecular docking.
Rastegar M et al.
Archives of Virology, 2021
Whole genome mapping and identification of single nucleotide polymorphisms of four Bangladeshi individuals and their functional significance.
Khan S et al.
Bmc Research Notes, 2021
Biased Coupling to β-Arrestin of Two Common Variants of the CB2 Cannabinoid Receptor.
Turu G et al.
Frontiers in Endocrinology, 2021
High throughput profiling of undifferentiated pleomorphic sarcomas identifies two main subgroups with distinct immune profile, clinical outcome and sensitivity to targeted therapies.
Toulmonde M et al.
Ebiomedicine, 2020
Association of cannabinoid receptor genes (CNR1 and CNR2) polymorphisms and panic disorder.
Peiró AM et al.
Anxiety, Stress, and Coping, 2020
Cannabinoid CB2 Receptor Functional Variation (Q63R) Is Associated with Multiple Sclerosis in Iranian Subjects.
Tahamtan A et al.
Journal of Molecular Neuroscience : Mn, 2020
The association of endocannabinoid receptor genes (CNR1 and CNR2) polymorphisms with depression: A meta-analysis.
Kong X et al.
Medicine, 2019
Gene-environment interaction between an endocannabinoid system genetic polymorphism and cannabis use in first episode of psychosis.
Bioque M et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology, 2019
Insights into paediatric non-alcoholic fatty liver disease from genetic variants.
Dong J et al.
Liver International : Official Journal of the International Association for the Study of the Liver, 2019
The role of GPCRs in bone diseases and dysfunctions.
Luo J et al.
Bone Research, 2019
Association of SP-B gene 9306 A/G polymorphism (rs7316) and risk of RDS.
Fatahi N et al.
The Journal of Maternal-fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 2018
Study of cannabinoid receptor 2 Q63R gene polymorphism in Lebanese patients with rheumatoid arthritis.
Ismail M et al.
Clinical Rheumatology, 2018
In vivo evidence that the cannabinoid receptor 2-63 RR variant is associated with the acquisition and/or expansion of HIV infection.
Sagnelli C et al.
Hiv Medicine, 2018
Genetic Variant Q63R of Cannabinoid Receptor 2 Causes Differential ERK Phosphorylation in Human Immune Cells.
Wang J et al.
Genetic Testing and Molecular Biomarkers, 2018
Genome-Wide Associations Related to Hepatic Histology in Nonalcoholic Fatty Liver Disease in Hispanic Boys.
Wattacheril J et al.
The Journal of Pediatrics, 2017
Phenotypic screening of cannabinoid receptor 2 ligands shows different sensitivity to genotype.
Hillger JM et al.
Biochemical Pharmacology, 2017
Role of Cannabinoid CB2 Receptor Gene (CNR2) Polymorphism in Children with Immune Thrombocytopenic Purpura in Beni-Suef Governorate in Egypt.
Ezzat DA et al.
The Egyptian Journal of Immunology, 2017
Cannabinoid receptor 2-63 RR variant is independently associated with severe necroinflammation in HIV/HCV coinfected patients.
Sagnelli C et al.
Plos One, 2017
CB2-63 polymorphism and immune-mediated diseases associated with HCV chronic infection.
Coppola N et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2016
Cannabinoid Receptor 2 as Antiobesity Target: Inflammation, Fat Storage, and Browning Modulation.
Rossi F et al.
The Journal of Clinical Endocrinology and Metabolism, 2016
Whole genome sequencing of an ethnic Pathan (Pakhtun) from the north-west of Pakistan.
Ilyas M et al.
Bmc Genomics, 2015
Association between cannabinoid receptor type 2 Q63R variant and oligo/polyarticular juvenile idiopathic arthritis.
Bellini G et al.
Scandinavian Journal of Rheumatology, 2015
The Cannabinoid Receptor 2 Q63R Variant Modulates the Relationship between Childhood Obesity and Age at Menarche.
Bellini G et al.
Plos One, 2015
No association between the functional cannabinoid receptor type 2 Q63R variants and inflammatory bowel disease in Turkish subjects.
Yonal O et al.
The Turkish Journal of Gastroenterology : the Official Journal of Turkish Society of Gastroenterology, 2014
Association between a polymorphism in cannabinoid receptor 2 and severe necroinflammation in patients with chronic hepatitis C.
Coppola N et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association, 2014
Effect of a poly(ADP-ribose) polymerase-1 inhibitor against esophageal squamous cell carcinoma cell lines.
Nasuno T et al.
Cancer Science, 2014
Cannabinoid receptor 2-63 QQ variant is associated with persistently normal aminotransferase serum levels in chronic hepatitis C.
Coppola N et al.
Plos One, 2014
Evidence for the involvement of cannabinoid receptors' polymorphisms in the pathophysiology of human diseases.
Vasileiou I et al.
Expert Opinion on Therapeutic Targets, 2013
Cannabinoid CB2 receptor gene (CNR2) polymorphism is associated with chronic childhood immune thrombocytopenia in Egypt.
Mahmoud Gouda H et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis, 2013
The cannabinoid receptor type 2 Q63R variant increases the risk of celiac disease: implication for a novel molecular biomarker and future therapeutic intervention.
Rossi F et al.
Pharmacological Research, 2012
Cannabinoid receptor type 2 functional variant influences liver damage in children with non-alcoholic fatty liver disease.
Rossi F et al.
Plos One, 2012